TAF with a boosted protease inhibitor: Clinical Trials

1 trial of TAF with a boosted protease inhibitor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow TAF with a boosted protease inhibitor: new trials by email Literature Review of TAF with a boosted protease inhibitor trials Research Report on TAF with a boosted protease inhibitor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Ledipasvir/Sofosbuvir on the Pharmacokinetics and Renal Safety of Tenofovir Alafenamide (TAF)
TDF with a boosted protease inhibitor, TAF with a boosted protease inhibitor, TAF with a boosted protease inhibitor and LDV/SOF - Hepatitis C, HIV Coinfection
Phase 4CompletedUniversity of Colorado, Denver102018-01-082021-02-11

Conditions studied

HIV Infections (1)  ·  Hepatitis C (1)

Sponsors

University of Colorado, Denver (1)

Countries

United States (1)

Top investigators

Jennifer J Kiser, PharmD (1)